Skip to main content
. 2021 Mar 5;14(11):2365–2370. doi: 10.1093/ckj/sfab053

Table 1.

HantaReg information categories documented.

Category Subcategory
Epidemiology Age group at diagnosis, sex, weight, year and place of infection, ethnicity, occupation
Pre-existing diseases Malignancy, HIV/AIDS, solid organ transplantation, chronic renal disease, chronic liver disease, chronic cardiovascular disease, chronic pulmonary disease and autoimmune disorder
Clinical presentation Signs and symptoms including vital signs at admission, after 24 and 72 h and at the day of discharge, disease course, HFRS, HCPS
Diagnostics Virological analyses and imaging procedures for the diagnosis of hantavirus infection, laboratory blood and urine results
Therapeutic approach Admission to ICU; antiviral and diuretic treatment approaches (drug, dose, duration, administration and adverse effects), renal replacement therapy (indication, mode of dialysis, duration and adverse effects), mechanical ventilation (duration), ECMO
Outcome Outcome of hantavirus diseases, time of hospitalization, readmission to the hospital, long term outcome on kidney function, development of chronic disease after hantavirus disease

AIDS, acquired immunodeficiency syndrome; ECMO, extracorporeal membrane oxygenation; HCPS, hantavirus cardiopulmonary syndrome; HFRS, haemorrhagic fever with renal syndrome; HIV, human immunodeficiency virus; ICU, intensive care unit.